
Sign up to save your podcasts
Or


This week’s View examines the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination in patients <21 years of age; the effect of empagliflozin in patients with heart failure across the spectrum of LVEF; and the safety and immunogenicity profiles of different COVID-19 vaccine booster regimens.
Subscribe to Eagle’s Eye View
By American College of Cardiology4.7
129129 ratings
This week’s View examines the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination in patients <21 years of age; the effect of empagliflozin in patients with heart failure across the spectrum of LVEF; and the safety and immunogenicity profiles of different COVID-19 vaccine booster regimens.
Subscribe to Eagle’s Eye View

134 Listeners

321 Listeners

504 Listeners

167 Listeners

906 Listeners

298 Listeners

1,150 Listeners

65 Listeners

39 Listeners

194 Listeners

94 Listeners

367 Listeners

437 Listeners

375 Listeners

32 Listeners